Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics

Category

Published in:

Frontiers in Pharmacology  
Vol. 14 (06.06.2023)

Volume:

14

Date Issued:

06.06.2023

DOI:

10.3389/fphar.2023.1229673

Language:

English

Type of Resource:

Text

Keywords:

COVID-19; kinase inhibitors; cancer; hepatocellular carcinoma; JAKs; FDA

DDC subject of DNB:

610 Medical sciences Medicine